DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Comparison of NSAID Patch Given in Monotherapy and NSAID Patch in Combination With Transcutaneous Electric Nerve Stimulation, Heating Pad, or Topical Capsaicin in the Treatment of Patients With Myofascial Pain Syndrome of the Upper Trapezius: A Pilot Study

Information source: Yonsei University
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Myofascial Pain Syndrome of the Upper Trapezius

Intervention: NSAID patch (Drug); NSAID patch + transcutaneous electric nerve stimulation (Drug); NSAID patch + heating pad (Drug); NSAID patch + topical capsaicin (Drug)

Phase: N/A

Status: Completed

Sponsored by: Yonsei University


Myofascial pain syndrome (MPS) is a common clinical problem of musculoskeletal pain and various treatment modalities have been introduced. If self-applicable physical modalities and medications that are used for treatment of MPS patients are combined, they may open up new possibilities for effective and practical self-care. The aim of this study is to compared the therapeutic effect of non-steroidal anti-inflammatory drug (NSAID) patch given in monotherapy and NSAID patch in combination with transcutaneous electric nerve stimulation, heating pad, or topical capsaicin in the treatment of patients with MPS of the upper trapezius.

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)

Primary outcome: The differences of the VAS pain scores


Minimum age: 20 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria: 1. Patients over 20 years of age with diagnosis of myofascial pain syndrome of the upper trapezius. 2. Visual analogue scale (VAS, 0 = no pain, 10 = worst pain) greater than Exclusion Criteria: 1. Pregnant or breast feeding women, patients who have taken opioids within seven days, patients with severe disease (heart disease, liver disease, etc) that might affect the results of the study, patients who have participated in another clinical study within 30 days.

Locations and Contacts

Severance Hospital, Seoul 120-752, Korea, Republic of
Additional Information

Related publications:

Al-Shaikh B, George William M, Van Zundert AA. Using atmospheric pressure to inflate the cuff of the Portex Laryngeal Mask. Anaesthesia. 2005 Mar;60(3):296-7.

Starting date: March 2011
Last updated: June 18, 2013

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017